Healthcare - Biotechnology - NASDAQ - US
$ 1.0
0 %
$ 1.55 M
Market Cap
-0.16
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
-0.00%
Net Income
Estimate
-0.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Kiromic BioPharma, Inc.
KRBP has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart KRBP
EBIT FORECAST
EBIT Forecast Chart KRBP
NET INCOME FORECAST
Net Income Chart KRBP